Refine
Document Type
- Article (6)
Has Fulltext
- yes (6)
Is part of the Bibliography
- no (6)
Keywords
- COVID-19 (2)
- SARS-CoV-2 (2)
- CVID (1)
- European Society for Immunodeficiencies (ESID) (1)
- FFP3 respirator (1)
- German PID-NET registry (1)
- Health care workers (1)
- IgG substitution therapy (1)
- Medical history (1)
- Otorhinolaryngological (1)
Institute
Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs.
Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel.
Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1–25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36% of patients. Familial cases were observed in 21% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0–88 years). Presenting symptoms comprised infections (74%) and immune dysregulation (22%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE- syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49% of all patients received immunoglobulin G (IgG) substitution (70%—subcutaneous; 29%—intravenous; 1%—unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy.
Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment.
Die Zielsetzung der vorliegenden Studie liegt darin, Bedarfe für eine Qualifizierung und Professionalisierung von Lehrkräften in inklusiven Schulen zu identifizieren. Dabei stehen sowohl spezifische Lehrer*innengruppen als auch konkrete Inhalte bzw. Anforderungen von Inklusion im Fokus. Den Rahmen hierfür bilden Schulen mit dem Schulprofil Inklusion (N = 471 Lehrkräfte aus 49 Schulen). Mittels hierarchischer Clusteranalyse (Überprüfung durch Diskriminanzanalyse) werden Gruppen von Lehrer*innen gebildet. Diese basieren darauf, wie die Lehrkräfte berichten, die Anforderungen von Inklusion (adaptive Unterrichtsgestaltung, Förderplanung, Schulkonzeptentwicklung, innerschulische und externe Kooperation) umzusetzen. Die Betrachtung der vier Cluster zeigt eine Gruppe von Lehrer*innen, die die Anforderungen inklusiver Bildung durchwegs am intensivsten realisiert. Diese machen deutlich, dass nicht für alle Lehrenden gleichermaßen die Notwendigkeit einer Qualifizierung besteht. Gleiches gilt für die Konzeption einheitlicher Maßnahmen, denn für alle Lehrkräfte identische Maßnahmen werden der Diversität der geäußerten Einschätzungen nicht gerecht. Zielführender erscheinen mikrokontextuell orientierte Maßnahmen, die auf bestimmte Lehrkräfte und Anforderungen zugeschnitten sind. Solche Bedarfe zielen einerseits auf die Lehrer*innen ab, die die Anforderungen von Inklusion übergreifend als am geringsten verwirklicht einschätzen sowie diejenigen, die bestimmte Anforderungen nicht umsetzen. Für diese sind Gründe und folgend Maßnahmen zu diskutieren, warum die Umsetzung durchwegs eine so negative Einschätzung erfährt. Maßnahmen im Kontext von Schulentwicklung oder Supervision erscheinen zielführend. Spezifische Qualifizierungsbedarfe bestehen vor allem hinsichtlich innerschulischer Zusammenarbeit, die sich clusterübergreifend als eher gering ausgeprägt erweist.
Background: Due to the coronavirus disease 2019 (COVID-19) pandemic, interventions in the upper airways are considered high-risk procedures for otolaryngologists and their colleagues. The purpose of this study was to evaluate limitations in hearing and communication when using a powered air-purifying respirator (PAPR) system to protect against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) transmission and to assess the benefit of a headset. Methods: Acoustic properties of the PAPR system were measured using a head and torso simulator. Audiological tests (tone audiometry, Freiburg speech test, Oldenburg sentence test (OLSA)) were performed in normal-hearing subjects (n = 10) to assess hearing with PAPR. The audiological test setup also included simulation of conditions in which the target speaker used either a PAPR, a filtering face piece (FFP) 3 respirator, or a surgical face mask. Results: Audiological measurements revealed that sound insulation by the PAPR headtop and noise, generated by the blower-assisted respiratory protection system, resulted in significantly deteriorated hearing thresholds (4.0 ± 7.2 dB hearing level (HL) vs. 49.2 ± 11.0
The current pandemic situation caused by the Betacoronavirus SARS-CoV-2 (SCoV2) highlights the need for coordinated research to combat COVID-19. A particularly important aspect is the development of medication. In addition to viral proteins, structured RNA elements represent a potent alternative as drug targets. The search for drugs that target RNA requires their high-resolution structural characterization. Using nuclear magnetic resonance (NMR) spectroscopy, a worldwide consortium of NMR researchers aims to characterize potential RNA drug targets of SCoV2. Here, we report the characterization of 15 conserved RNA elements located at the 5′ end, the ribosomal frameshift segment and the 3′-untranslated region (3′-UTR) of the SCoV2 genome, their large-scale production and NMR-based secondary structure determination. The NMR data are corroborated with secondary structure probing by DMS footprinting experiments. The close agreement of NMR secondary structure determination of isolated RNA elements with DMS footprinting and NMR performed on larger RNA regions shows that the secondary structure elements fold independently. The NMR data reported here provide the basis for NMR investigations of RNA function, RNA interactions with viral and host proteins and screening campaigns to identify potential RNA binders for pharmaceutical intervention.
Purpose: Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) replicates predominantly in the upper respiratory tract and is primarily transmitted by droplets and aerosols. Taking the medical history for typical COVID-19 symptoms and PCR-based SARS-CoV-2 testing have become established as screening procedures. The aim of this work was to describe the clinical appearance of SARS-CoV-2-PCR positive patients and to determine the SARS-CoV-2 contact risk for health care workers (HCW).
Methods: The retrospective study included n = 2283 SARS-CoV-2 PCR tests from n = 1725 patients with otorhinolaryngological (ORL) diseases performed from March to November 2020 prior to inpatient treatment. In addition, demographic data and medical history were assessed.
Results: n = 13 PCR tests (0.6%) were positive for SARS-CoV-2 RNA. The positive rate showed a significant increase during the observation period (p < 0.01). None of the patients had clinical symptoms that led to a suspected diagnosis of COVID-19 before PCR testing. The patients were either asymptomatic (n = 4) or had symptoms that were interpreted as symptoms typical of the ORL disease or secondary diagnoses (n = 9).
Conclusion: The identification of SARS-CoV-2-positive patients is a considerable challenge in clinical practice. Our findings illustrate that taking a medical history alone is of limited value and cannot replace molecular SARS-CoV-2 testing, especially for patients with ORL diseases. Our data also demonstrate that there is a high probability of contact with SARS-CoV-2-positive patients in everyday clinical practice, so that the use of personal protective equipment, even in apparently “routine cases”, is highly recommended.